Hikma Pharmaceuticals USA Inc. — H1B Data for FY2023
FY2023 H1B Overview for Hikma Pharmaceuticals USA Inc.
In fiscal year 2023, Hikma Pharmaceuticals USA Inc. filed 7 H1B labor condition applications with the U.S. Department of Labor. Of these, 4 were certified and 0 were denied. The average salary offered on these applications was $113,106.
The applications covered a total of 7 worker positions, as a single LCA can cover multiple workers in the same role and location.
Hikma Pharmaceuticals USA Inc. also filed 5 PERM (green card) applications in FY2023, with 1 certified, indicating ongoing commitment to long-term sponsorship for foreign workers.
View Hikma Pharmaceuticals USA Inc.'s complete sponsorship history on the full employer profile, including all years, job titles, and salary trends. Learn more about the H1B visa program in our comprehensive H1B visa guide.
FY2023 H1B Filings by Hikma Pharmaceuticals USA Inc.
Individual labor condition applications filed by Hikma Pharmaceuticals USA Inc. in fiscal year 2023. There are 7 filings total.
| Case # | Status | Job Title | Salary | Location | Date |
|---|---|---|---|---|---|
| I-200-23255-340867 | Certified | Senior Scientist, Analytical Research | $106,850 – $108,160 | Bedford, OH | 2023-09-29 |
| I-200-23255-340985 | Certified | Principal Scientist, Analytical Research | $104,562 | Columbus, OH | 2023-09-19 |
| I-200-23249-323541 | Certified | Sr. Scientist, Analytical Research | $95,000 – $100,000 | Bedford, OH | 2023-09-13 |
| I-200-23234-284939 | Certified | Principal Scientist, Analytical Research | $104,562 – $106,605 | Columbus, OH | 2023-08-29 |
| I-200-23234-284929 | Certified | Principal Scientist, Formulation Development | $104,562 – $124,200 | Columbus, OH | 2023-08-29 |
| I-200-23221-249961 | Withdrawn | Associate Principal Architect SAP PP/QM | $146,474 – $165,000 | Cherry Hill, NJ | 2023-08-11 |
| I-200-20160-634868 | Certified | Senior SAP BI Analyst | $129,730 | Columbus, OH | 2023-07-06 |
Hikma Pharmaceuticals USA Inc. H1B History by Year
Browse Hikma Pharmaceuticals USA Inc.'s H1B filing data for other fiscal years.